Allos Therapeutics Newswire
Results 1 - 2 of 2 in Allos Therapeutics
... Strategy LLC. He has served as the chief financial officer of Genomica Corp., Rally Development Corp. and Allos Therapeutics. is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total ... Comment?
Allos Therapeutics, Inc., a biopharmaceutical company, engaged in the development and commercialization of small molecule therapeutics for the treatment of cancer. Its lead product candidate, FOLOTYN , a novel antifolate has completed a pivotal phase 2 trial in patients, a targeted chemotherapeutic agent, treats advanced solid tumors. Comment?
- « Previous
- Next »
Copyright © 2015 Topix LLC